| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |